Hoechst PakistanKAR:HPL 86 OCF Yield % is 9.81 as of Jun. 29, 2026, which is 6% above its 10-year median of 9.24. GuruFocus rates KAR:HPL with a GF Score™ of 86/100 and a GF Value™ of ₨3,253.76 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 1,002 Drug Manufacturers companies, Hoechst Pakistan ranks better than 77.64% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Hoechst Pakistan OCF Yield % Related Terms
Hoechst Pakistan OCF Yield % Historical Data
* Premium members only.
The historical data trend for Hoechst Pakistan's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Hoechst Pakistan's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hoechst Pakistan OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hoechst Pakistan's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Hoechst Pakistan's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hoechst Pakistan (KAR:HPL) has a OCF Yield % of 9.81 as of Jun. 29, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Hoechst Pakistan and its competitors. This is near median its historical median of 9.24. According to the industry distribution chart, Hoechst Pakistan ranks #224 out of 1002 companies in the Drug Manufacturers industry, placing it in the top 22.4%.
Is Hoechst Pakistan's OCF Yield % too high?
Hoechst Pakistan's current OCF Yield % of 9.81 is near median its 10-year median of 9.24. The Drug Manufacturers industry median OCF Yield % is 3.61. Hoechst Pakistan's value of 9.81 is 171.7% above this industry median. Based on the distribution chart, Hoechst Pakistan ranks #224 out of 1002 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hoechst Pakistan has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hoechst Pakistan's OCF Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Hoechst Pakistan ranks #224 out of 1002 companies for OCF Yield %. This places Hoechst Pakistan in the top 22% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.61. Hoechst Pakistan's value of 9.81 is 171.7% above this benchmark. While the company's 10-year median is 9.24 vs. the industry median of 3.61, Hoechst Pakistan has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.61, based on 1,002 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hoechst Pakistan's current OCF Yield % of 9.81 is 171.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Hoechst Pakistan and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hoechst Pakistan's current OCF Yield % is 9.81, which is near median its own 10-year median of 9.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hoechst Pakistan stock overvalued right now?
Based on GuruFocus' analysis, Hoechst Pakistan (KAR:HPL) is currently considered Modestly Overvalued. The stock's GF Value™ is ₨3,253.76, compared to a current price of ₨4,015.00 — trading 23.4% above its estimated fair value. The current OCF Yield % is 9.81, which is near median its 10-year median of 9.24 and 171.7% above the Drug Manufacturers industry median of 3.61. Hoechst Pakistan's overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Hoechst Pakistan (KAR:HPL), the current OCF Yield % is 9.81 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hoechst Pakistan (KAR:HPL) Overvalued in 2026?
Based on GuruFocus' analysis, Hoechst Pakistan stock appears to be overvalued.
The current stock price of ₨4,015.00 is trading 23.4% above its estimated GF Value™ of ₨3,253.76.
GuruFocus considers Hoechst Pakistan to be Modestly Overvalued.
Key valuation signals for KAR:HPL:
OCF Yield %: 9.81 (near median its 10-year median of 9.24)
GF Value™: ₨3,253.76 vs. price of ₨4,015.00 (23.4% above fair value)
Industry Position: 171.7% above the Drug Manufacturers median (#224 of 1002)
No single metric tells the full story. See the KAR:HPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hoechst Pakistan Ltd is a healthcare company of Pakistan, focused on patient needs and engaged in the manufacturing, promotion, and sale of pharmaceutical and vaccines. The company engages in the manufacturing, selling and trading of pharmaceutical and related products.
86GF Score
Get the complete analysis for KAR:HPL
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KAR:HPL has been successfully added to your 
